15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Mediwound Ltd, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $32.00 to $36.00, so the covering firms are broadly aligned. The average target of $34.00 sits 132% above the current $14.66. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 1 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.71 next quarter toward $-2.22 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Strong Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Mediwound Ltd.
As of Jul, 2 of 2 firms rate MDWD a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MDWD EPS & revenue forecast
EPS · NEXT QUARTER
$-0.71
Range $-0.87 – $-0.49 · 5 analysts · +194% YoY
Next period, 5 analysts expect Mediwound Ltd to earn $-0.71 a share (range $-0.87 – $-0.49), versus $-0.24 a year earlier. Full-year consensus is $-2.38, growing to $-2.22 the year after.
REVENUE · NEXT QUARTER
$8.7M
Range $6.8M – $10.1M · 5 analysts · +60% YoY
Revenue is expected to reach $8.7M (range $6.8M – $10.1M), +60.2% year-over-year. Full-year consensus is $24.1M, rising to $32.9M next year.
Top analysts covering Mediwound Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MDWD.
#1
Chase Knickerbocker
Craig-Hallum · Rank #25
Buy
No targeton MDWD
Overall win rate
58%
+ Follow
#2
Francois Brisebois
Oppenheimer · Rank #186
Buy
$32.00+118.2% to target
Overall win rate
40%
+ Follow
#3
Swayampakula Ramakanth
HC Wainwright & Co. · Rank #230
Buy
$36.00+145.5% to target
Overall win rate
37%
+ Follow
#4
JJ
Josh Jennings
TD Cowen
Buy
$25.00+70.5% to target
Coverage
—
+ Follow
#5
Michael Okunewitch
Maxim Group
Buy
$30.00+104.6% to target
Coverage
—
+ Follow
MDWD stock forecast FAQ
What is MDWD's average 12-month price target?+
The 2 analysts with a live target average $34.00 for Mediwound Ltd over the next 12 months, ranging from a $36.00 high to a $32.00 low.
Is MDWD stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MDWD?+
The Street-high target is $36.00 (HC Wainwright & Co.), and the Street-low is $32.00 (Oppenheimer). The average of all 2 active targets is $34.00.
How many Wall Street analysts cover MDWD?+
2 analysts have an active rating on Mediwound Ltd, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering MDWD?+
Among analysts who currently cover MDWD, Chase Knickerbocker of Craig-Hallum has the strongest overall Quantellect track record (Rank #25). Their current call is Buy.
What is Mediwound Ltd's projected EPS for next quarter?+
The consensus estimate is $-0.71 per share (range $-0.87 – $-0.49) across 5 analysts. Full-year EPS is projected at $-2.38, rising to $-2.22 the following year.
How much revenue is Mediwound Ltd expected to report next quarter?+
Consensus revenue is $8.7M (range $6.8M – $10.1M). Full-year revenue is projected at $24.1M, growing to $32.9M next year.
Have analysts been upgrading or downgrading MDWD lately?+
As of Jul, 2 of 2 firms rate MDWD a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MDWD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
